ACCURAY INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ACCURAY INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Jun 30, 2018 | $113.79M | Aug 24, 2018 |
| FY2018 | Mar 31, 2018 | $99.83M | Aug 24, 2018 |
| FY2018 | Dec 31, 2017 | $100.33M | Aug 24, 2018 |
| FY2018 | Sep 30, 2017 | $90.95M | Aug 24, 2018 |
| FY2018 | Jun 30, 2017 | $112.09M | Aug 24, 2018 |
| FY2018 | Mar 31, 2017 | $97.31M | Aug 24, 2018 |
| FY2018 | Dec 31, 2016 | $87.50M | Aug 24, 2018 |
| FY2018 | Sep 30, 2016 | $86.51M | Aug 24, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $458.51M | Feb 17, 2026 |
| FY2025 | Jun 30, 2024 | $446.55M | Feb 17, 2026 |
| FY2024 | Jun 30, 2023 | $447.61M | Sep 19, 2024 |
| FY2024 | Jun 30, 2022 | $429.91M | Sep 19, 2024 |
| FY2021 | Jun 30, 2021 | $110.94M | Aug 17, 2021 |
| FY2021 | Mar 31, 2021 | $102.56M | Aug 17, 2021 |
| FY2021 | Dec 31, 2020 | $97.46M | Aug 17, 2021 |
| FY2021 | Sep 30, 2020 | $85.33M | Aug 17, 2021 |
| FY2021 | Jun 30, 2020 | $94.98M | Aug 17, 2021 |
| FY2021 | Mar 31, 2020 | $99.55M | Aug 17, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jun 30, 2017 | $112.09M | Aug 25, 2017 |
| FY2017 | Mar 31, 2017 | $97.31M | Aug 25, 2017 |
| FY2017 | Dec 31, 2016 | $87.50M | Aug 25, 2017 |
| FY2017 | Sep 30, 2016 | $86.51M | Aug 25, 2017 |
| FY2017 | Jun 30, 2016 | $94.97M | Aug 25, 2017 |
| FY2017 | Mar 31, 2016 | $105.28M | Aug 25, 2017 |
| FY2017 | Dec 31, 2015 | $108.91M | Aug 25, 2017 |
| FY2017 | Sep 30, 2015 | $89.63M | Aug 25, 2017 |
| FY2016 | Jun 30, 2015 | $101.75M | Aug 24, 2016 |
| FY2016 | Mar 31, 2015 | $97.52M | Aug 24, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $146.97M | Feb 17, 2026 |
| FY2025 | Jun 30, 2024 | $142.92M | Feb 17, 2026 |
| FY2024 | Jun 30, 2023 | $153.96M | Sep 19, 2024 |
| FY2024 | Jun 30, 2022 | $159.96M | Sep 19, 2024 |
| FY2021 | Jun 30, 2021 | $43.73M | Aug 17, 2021 |
| FY2021 | Mar 31, 2021 | $39.54M | Aug 17, 2021 |
| FY2021 | Dec 31, 2020 | $40.83M | Aug 17, 2021 |
| FY2021 | Sep 30, 2020 | $35.40M | Aug 17, 2021 |
| FY2021 | Jun 30, 2020 | $39.75M | Aug 17, 2021 |
| FY2021 | Mar 31, 2020 | $39.13M | Aug 17, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($1.59M) | Feb 17, 2026 |
| FY2025 | Jun 30, 2024 | ($15.55M) | Feb 17, 2026 |
| FY2024 | Jun 30, 2023 | ($9.28M) | Sep 19, 2024 |
| FY2024 | Jun 30, 2022 | ($5.35M) | Sep 19, 2024 |
| FY2021 | Jun 30, 2021 | ($11.09M) | Aug 17, 2021 |
| FY2021 | Mar 31, 2021 | ($390.0K) | Aug 17, 2021 |
| FY2021 | Dec 31, 2020 | $4.77M | Aug 17, 2021 |
| FY2021 | Sep 30, 2020 | $402.0K | Aug 17, 2021 |
| FY2021 | Jun 30, 2020 | ($152.0K) | Aug 17, 2021 |
| FY2021 | Mar 31, 2020 | $2.63M | Aug 17, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $7.84M | Feb 17, 2026 |
| FY2025 | Jun 30, 2024 | $504.0K | Feb 17, 2026 |
| FY2024 | Jun 30, 2023 | $2.38M | Sep 19, 2024 |
| FY2024 | Jun 30, 2022 | $8.15M | Sep 19, 2024 |
| FY2023 | Jun 30, 2021 | $22.24M | Sep 7, 2023 |
| FY2022 | Jun 30, 2020 | $12.54M | Aug 17, 2022 |
| FY2021 | Jun 30, 2019 | $583.0K | Aug 17, 2021 |
| FY2020 | Jun 30, 2018 | ($3.80M) | Aug 25, 2020 |
| FY2019 | Jun 30, 2017 | ($9.82M) | Aug 23, 2019 |
| FY2018 | Jun 30, 2016 | ($4.87M) | Aug 24, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $47.94M | Feb 17, 2026 |
| FY2025 | Jun 30, 2024 | $49.73M | Feb 17, 2026 |
| FY2024 | Jun 30, 2023 | $57.13M | Sep 19, 2024 |
| FY2024 | Jun 30, 2022 | $57.75M | Sep 19, 2024 |
| FY2023 | Jun 30, 2021 | $52.73M | Sep 7, 2023 |
| FY2022 | Jun 30, 2020 | $49.78M | Aug 17, 2022 |
| FY2021 | Jun 30, 2019 | $56.49M | Aug 17, 2021 |
| FY2020 | Jun 30, 2018 | $57.25M | Aug 25, 2020 |
| FY2019 | Jun 30, 2017 | $49.92M | Aug 23, 2019 |
| FY2018 | Jun 30, 2016 | $56.65M | Aug 24, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.86M | Feb 17, 2026 |
| FY2025 | Jun 30, 2024 | ($11.90M) | Feb 17, 2026 |
| FY2024 | Jun 30, 2023 | $15.54M | Sep 19, 2024 |
| FY2024 | Jun 30, 2022 | ($2.40M) | Sep 19, 2024 |
| FY2023 | Jun 30, 2021 | $38.51M | Sep 7, 2023 |
| FY2022 | Jun 30, 2020 | ($1.47M) | Aug 17, 2022 |
| FY2021 | Jun 30, 2019 | ($29.64M) | Aug 17, 2021 |
| FY2020 | Jun 30, 2018 | $18.33M | Aug 25, 2020 |
| FY2019 | Jun 30, 2017 | ($380.0K) | Aug 23, 2019 |
| FY2018 | Jun 30, 2016 | $30.93M | Aug 24, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $4.27M | Feb 17, 2026 |
| FY2025 | Jun 30, 2024 | $3.60M | Feb 17, 2026 |
| FY2024 | Jun 30, 2023 | $12.61M | Sep 19, 2024 |
| FY2024 | Jun 30, 2022 | $4.72M | Sep 19, 2024 |
| FY2023 | Jun 30, 2021 | $2.32M | Sep 7, 2023 |
| FY2022 | Jun 30, 2020 | $3.56M | Aug 17, 2022 |
| FY2021 | Jun 30, 2019 | $4.31M | Aug 17, 2021 |
| FY2020 | Jun 30, 2018 | $6.28M | Aug 25, 2020 |
| FY2019 | Jun 30, 2017 | $5.03M | Aug 23, 2019 |
| FY2018 | Jun 30, 2016 | $8.07M | Aug 24, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $470.24M | Feb 17, 2026 |
| FY2025 | Jun 30, 2024 | $468.63M | Feb 17, 2026 |
| FY2024 | Jun 30, 2023 | $479.21M | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | $472.85M | Sep 7, 2023 |
| FY2022 | Jun 30, 2021 | $480.10M | Aug 17, 2022 |
| FY2021 | Jun 30, 2020 | $490.93M | Aug 17, 2021 |
| FY2020 | Jun 30, 2019 | $438.18M | Aug 25, 2020 |
| FY2019 | Jun 30, 2018 | $378.73M | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | $406.46M | Aug 24, 2018 |
| FY2017 | Jun 30, 2016 | $469.03M | Aug 25, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $389.07M | Feb 17, 2026 |
| FY2025 | Jun 30, 2024 | $423.54M | Feb 17, 2026 |
| FY2024 | Jun 30, 2023 | $425.56M | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | $419.66M | Sep 7, 2023 |
| FY2022 | Jun 30, 2021 | $411.26M | Aug 17, 2022 |
| FY2021 | Jun 30, 2020 | $427.29M | Aug 17, 2021 |
| FY2020 | Jun 30, 2019 | $388.31M | Aug 25, 2020 |
| FY2019 | Jun 30, 2018 | $330.10M | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | $359.93M | Aug 24, 2018 |
| FY2017 | Jun 30, 2016 | $409.37M | Aug 25, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $81.17M | Feb 17, 2026 |
| FY2025 | Jun 30, 2024 | $45.08M | Feb 17, 2026 |
| FY2025 | Jun 30, 2023 | $53.66M | Feb 17, 2026 |
| FY2024 | Jun 30, 2022 | $53.19M | Sep 19, 2024 |
| FY2024 | Jun 30, 2021 | $68.84M | Sep 19, 2024 |
| FY2023 | Jun 30, 2020 | $63.64M | Sep 7, 2023 |
| FY2022 | Jun 30, 2019 | $49.87M | Aug 17, 2022 |
| FY2021 | Jun 30, 2018 | $48.63M | Aug 17, 2021 |
| FY2020 | Jun 30, 2017 | $46.53M | Aug 25, 2020 |
| FY2019 | Jun 30, 2016 | $59.66M | Aug 23, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $57.80M | Feb 17, 2026 |
| FY2025 | Jun 30, 2024 | $57.67M | Feb 17, 2026 |
| FY2025 | Jun 30, 2023 | $57.68M | Feb 17, 2026 |
| FY2024 | Jun 30, 2022 | $57.84M | Sep 19, 2024 |
| FY2023 | Jun 30, 2021 | $57.96M | Sep 7, 2023 |
| FY2022 | Jun 30, 2020 | $57.72M | Aug 17, 2022 |
| FY2021 | Jun 30, 2019 | $57.77M | Aug 17, 2021 |
| FY2020 | Jun 30, 2018 | $57.86M | Aug 25, 2020 |
| FY2019 | Jun 30, 2017 | $57.81M | Aug 23, 2019 |
| FY2018 | Jun 30, 2016 | $57.85M | Aug 24, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($519.27M) | Feb 17, 2026 |
| FY2025 | Jun 30, 2024 | ($517.68M) | Feb 17, 2026 |
| FY2024 | Jun 30, 2023 | ($502.14M) | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | ($492.52M) | Sep 7, 2023 |
| FY2022 | Jun 30, 2021 | ($488.02M) | Aug 17, 2022 |
| FY2021 | Jun 30, 2020 | ($481.71M) | Aug 17, 2021 |
| FY2020 | Jun 30, 2019 | ($485.54M) | Aug 25, 2020 |
| FY2019 | Jun 30, 2018 | ($474.29M) | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | ($450.39M) | Aug 24, 2018 |
| FY2017 | Jun 30, 2016 | ($420.81M) | Aug 25, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $57.42M | Feb 17, 2026 |
| FY2025 | Jun 30, 2024 | $68.57M | Feb 17, 2026 |
| FY2024 | Jun 30, 2023 | $89.40M | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | $88.74M | Sep 7, 2023 |
| FY2022 | Jun 30, 2021 | $116.37M | Aug 17, 2022 |
| FY2021 | Jun 30, 2020 | $107.58M | Aug 17, 2021 |
| FY2020 | Jun 30, 2019 | $76.80M | Aug 25, 2020 |
| FY2019 | Jun 30, 2018 | $83.08M | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | $72.08M | Aug 24, 2018 |
| FY2017 | Jun 30, 2016 | $119.77M | Aug 25, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $136.52M | Feb 17, 2026 |
| FY2025 | Jun 30, 2024 | $172.16M | Feb 17, 2026 |
| FY2024 | Jun 30, 2023 | $177.28M | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | $180.47M | Sep 7, 2023 |
| FY2021 | Jun 30, 2021 | $173.80M | Aug 17, 2021 |
| FY2020 | Jun 30, 2020 | $189.31M | Aug 25, 2020 |
| FY2019 | Jun 30, 2019 | $159.84M | Aug 23, 2019 |
| FY2018 | Jun 30, 2018 | $131.08M | Aug 24, 2018 |
| FY2017 | Jun 30, 2017 | $164.57M | Aug 25, 2017 |
| FY2016 | Jun 30, 2016 | $210.41M | Aug 24, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Feb 17, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Feb 17, 2026 |
| FY2024 | Jun 30, 2023 | 0 | Sep 19, 2024 |
| FY2024 | Jun 30, 2022 | 0 | Sep 19, 2024 |
| FY2021 | Jun 30, 2021 | 0 | Aug 17, 2021 |
| FY2021 | Mar 31, 2021 | 0 | Aug 17, 2021 |
| FY2021 | Dec 31, 2020 | 0 | Aug 17, 2021 |
| FY2021 | Sep 30, 2020 | 0 | Aug 17, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Aug 25, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Aug 25, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Aug 28, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Sep 19, 2024 |
| FY2024 | Jun 30, 2022 | 0 | Sep 19, 2024 |
| FY2021 | Jun 30, 2021 | 0 | Aug 17, 2021 |
| FY2021 | Mar 31, 2021 | 0 | Aug 17, 2021 |
| FY2021 | Dec 31, 2020 | 0 | Aug 17, 2021 |
| FY2021 | Sep 30, 2020 | 0 | Aug 17, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Aug 25, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Aug 25, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 112.64M | Feb 17, 2026 |
| FY2025 | Jun 30, 2024 | 100.19M | Feb 17, 2026 |
| FY2024 | Jun 30, 2023 | 96.53M | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | 93.50M | Sep 7, 2023 |
| FY2022 | Jun 30, 2021 | 90.82M | Aug 17, 2022 |
| FY2021 | Jun 30, 2020 | 91.18M | Aug 17, 2021 |
| FY2020 | Jun 30, 2019 | 88.52M | Aug 25, 2020 |
| FY2019 | Jun 30, 2018 | 86.13M | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | 83.74M | Aug 24, 2018 |
| FY2017 | Jun 30, 2016 | 81.38M | Aug 25, 2017 |